Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Assessment of new oncological drugs].
Wymenga ANM. Wymenga ANM. Ned Tijdschr Geneeskd. 2022 Aug 17;166:D7105. Ned Tijdschr Geneeskd. 2022. PMID: 36300489 Dutch.
Vascular fingerprint tool to identify patients with testicular cancer treated with cisplatin-based chemotherapy at high risk of early cardiovascular events.
Meuleman AT, Volders ELD, Lubberts S, Kerst JM, Wymenga ANM, Aarts MJB, Goncalves MB, Lefrandt JD, Steursma G, Meijer J, Nuver J, Gietema JA. Meuleman AT, et al. Among authors: wymenga anm. ESMO Open. 2024 Jul;9(7):103631. doi: 10.1016/j.esmoop.2024.103631. Epub 2024 Jul 13. ESMO Open. 2024. PMID: 38996520 Free PMC article.
Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature.
Opdam M, van der Noort V, Kleijn M, Glas A, Mandjes I, Kleiterp S, Hilbers FS, Kruger DT, Bins AD, de Jong PC, Schiphorst PPJBM, van Dalen T, Flameling B, Rietbroek RC, Beeker A, van den Heiligenberg SM, Bakker SD, Wymenga ANM, Oving IM, Bijlsma RM, van Diest PJ, Vermorken JB, van Tinteren H, Linn SC. Opdam M, et al. Among authors: wymenga anm. Breast Cancer Res Treat. 2022 Jul;194(2):265-278. doi: 10.1007/s10549-022-06618-z. Epub 2022 May 19. Breast Cancer Res Treat. 2022. PMID: 35587322 Free PMC article. Clinical Trial.
Harmonising patient-access programmes: the Dutch DRUG Access Protocol platform.
Zeverijn LJ, van Waalwijk van Doorn-Khosrovani SB, van Roy AAMGP, Timmers L, Ly Tran TH, de Boer JE, de Wit GF, Geurts BS, Gelderblom H, Verheul HMW, Blijlevens N, Wymenga ANM, Eskens FALM, Smit EF, Bloemendal HJ, Voest EE. Zeverijn LJ, et al. Among authors: wymenga anm. Lancet Oncol. 2022 Feb;23(2):198-201. doi: 10.1016/S1470-2045(21)00707-5. Lancet Oncol. 2022. PMID: 35114116 No abstract available.
Prospective practice survey of management of cetuximab-related skin reactions.
Lugtenberg RT, Boers-Doets CB, Witteveen PO, van Herpen CML, Wymenga ANM, de Groot JWB, Hoeben A, Del Grande C, van Doorn B, Koldenhof JJ, Driessen CML, Gelderblom H. Lugtenberg RT, et al. Among authors: wymenga anm. Support Care Cancer. 2021 Jul;29(7):3497-3506. doi: 10.1007/s00520-020-05862-7. Epub 2020 Nov 4. Support Care Cancer. 2021. PMID: 33150521 Free PMC article.
Informal caregiver well-being during and after patients' treatment with adjuvant chemotherapy for colon cancer: a prospective, exploratory study.
Langenberg SMCH, Poort H, Wymenga ANM, de Groot JW, Muller EW, van der Graaf WTA, Prins JB, van Herpen CML. Langenberg SMCH, et al. Among authors: wymenga anm. Support Care Cancer. 2021 May;29(5):2481-2491. doi: 10.1007/s00520-020-05738-w. Epub 2020 Sep 15. Support Care Cancer. 2021. PMID: 32935205 Free PMC article.
36 results